chr15-88467975-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000325844.9(MRPS11):c.133G>A(p.Ala45Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000261 in 1,611,656 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000325844.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRPS11 | NM_022839.5 | c.133G>A | p.Ala45Thr | missense_variant | 2/6 | ENST00000325844.9 | NP_073750.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MRPS11 | ENST00000325844.9 | c.133G>A | p.Ala45Thr | missense_variant | 2/6 | 1 | NM_022839.5 | ENSP00000317376.4 | ||
ENSG00000173867 | ENST00000649547.1 | c.*756-2202C>T | intron_variant | ENSP00000497509.1 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152172Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000246 AC: 6AN: 243876Hom.: 0 AF XY: 0.0000151 AC XY: 2AN XY: 132632
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1459366Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 8AN XY: 725808
GnomAD4 genome AF: 0.000164 AC: 25AN: 152290Hom.: 0 Cov.: 32 AF XY: 0.000201 AC XY: 15AN XY: 74474
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 15, 2024 | The c.133G>A (p.A45T) alteration is located in exon 2 (coding exon 2) of the MRPS11 gene. This alteration results from a G to A substitution at nucleotide position 133, causing the alanine (A) at amino acid position 45 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at